In May 2012, the British Medical Journal published an article titled "Avastin versus Lucentis".
Notes on verification
Confirmed by multiple independent sources including citation databases, a peer-reviewed article reference, a slideshare reproduction of the original text, and contemporary trade press coverage, all matching the exact title and date (2 May 2012, BMJ 344:e3162). [tier=gold indep_score=0.838 clusters=4 claim_tier=everyday | kind=attributed eligibility=high]
Sources
- Procedura di infrazione da parte dell'Autorità Antitrust (seed:health_and_medicine)
- https://www.slideshare.net/slideshow/lucentis-fiona-godlee/12817878 (corroboration)
- https://link.springer.com/article/10.1007/s11096-013-9779-7 (corroboration)
- https://www.grafiati.com/en/literature-selections/lucentini/ (corroboration)
- https://pmlive.com/pharma_news/the_bmj_weighs_in_on_avastinlucentis_debate_699646/ (corroboration)